
Belrin-La 75mg/5mg/10mg Tablet
Marketer
Globus Remedies Ltd
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Belrin-La 75mg/5mg/10mg Tablet
RespiClear 75mg/5mg/10mg tablets are a multi-component medication prescribed for managing respiratory illnesses characterized by thick mucus. This treatment offers relief from productive coughs associated with conditions such as bronchial asthma, bronchitis, and the common cold. RespiClear 75mg/5mg/10mg tablets can be administered with or without food, following your physician's dosage and duration instructions. Your prescribed dose will be tailored to your specific needs and response. Continue taking this medication for the duration recommended by your doctor; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Commonly reported side effects include nausea, indigestion, dry mouth, flu-like symptoms, tiredness, and headache. Most are transient and resolve spontaneously. Consult your doctor promptly if any side effects are concerning. Drowsiness and dizziness are potential side effects; refrain from driving or tasks requiring alertness until the medication's impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Prior to commencing treatment, disclose any kidney or liver conditions to allow your doctor to adjust the dosage appropriately. Pregnant women, those planning pregnancy, and breastfeeding mothers should also inform their doctor.
Uses of Belrin-La 75mg/5mg/10mg Tablet
Managing respiratory conditions characterized by thick mucus.
Major Benefits of Belrin-La 75mg/5mg/10mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Belrin-La 75mg/5mg/10mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Belrin-La 75mg/5mg/10mg Tablet:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Belrin-La 75mg/5mg/10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Belrin-La 75mg/5mg/10mg Tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended.
How Belrin-La 75mg/5mg/10mg Tablet works:
Each Belrin-La 75mg/5mg/10mg tablet unites ambroxol, levocetirizine, and montelukast. Ambroxol, a mucolytic agent, facilitates expectoration by reducing mucus viscosity. Levocetirizine, an antihistamine, alleviates allergic manifestations such as rhinorrhea, lacrimation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby diminishing airway and nasal inflammation and improving associated symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Belrin-La 75mg/5mg/10mg tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Belrin-La 75mg/5mg/10mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Belrin-La 75mg/5mg/10mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Belrin-La 75mg/5mg/10mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Belrin-La 75mg/5mg/10mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. The use of Belrin-La 75mg/5mg/10mg tablets is contraindicated in individuals with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use Belrin-La 75mg/5mg/10mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Belrin-La 75mg/5mg/10mg Tablet :
Should you forget to take a Belrin-La 75mg/5mg/10mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Belrin-La 75mg/5mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Breathing |
